Outpatient drug safety: new steps in an old direction

Authors

  • Daniel S. Budnitz,

    Corresponding author
    1. Division of Healthcare Quality Promotion, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    • Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road, MS-A24, Atlanta, GA 30333, USA.
    Search for more papers by this author
  • Peter M. Layde

    1. Injury Research Center and Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI, USA
    Search for more papers by this author

  • This article is a U.S. Government work and is in the public domain in the U.S.A.

Abstract

Iatrogenic injury from adverse drug events (ADEs) is a common and often preventable problem in modern medical practice. Attention to this problem has focused on the inpatient hospital setting and healthcare professionals. However, most medication is prescribed and used outside of hospitals and is managed by patients or lay caregivers in homes or workplaces. To address the public health problem of outpatient drug safety, interventions to prevent adverse events must recognize the central role of the patient in medication management and environmental factors specific to the outpatient setting. Lessons and techniques from the field of injury prevention should guide the development and implementation of safety interventions. First, Haddon's phase-factor matrix can be used to help conceptualize outpatient drug safety interventions. Second, interventions to improve outpatient drug safety should be patient-centered and extend beyond patient education to include engineering innovations and enforcement strategies. Third, the sustainability of active versus passive interventions should be considered when choosing safety interventions. Published in 2006 by John Wiley & Sons, Ltd.

Ancillary